Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · October 27, 2024

Acquired Gene Alterations in Patients Treated With Endocrine Therapy ± Ribociclib Using Baseline and End-of-Treatment ctDNA Samples

Annals of Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Annals of Oncology
Acquired gene alterations in patients treated with ribociclib plus endocrine therapy or endocrine therapy alone using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2, -3, and -7 trials
Ann. Oncol 2024 Sep 21;[EPub Ahead of Print], F André, N Solovieff, F Su, A Bardia, P Neven, YS Yap, D Tripathy, YS Lu, D Slamon, S Chia, M Joshi, A Chakravartty, A Lteif, T Taran, CL Arteaga

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading